 Mohd Minhajuddin
Concepts (104)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intercellular Adhesion Molecule-1 | 7 | 2009 | 175 | 0.870 |
Why?
| | Thrombin | 7 | 2009 | 143 | 0.580 |
Why?
| | NF-kappa B | 5 | 2008 | 670 | 0.520 |
Why?
| | Protein Kinase C-delta | 2 | 2008 | 69 | 0.400 |
Why?
| | Endothelial Cells | 4 | 2009 | 732 | 0.390 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 1 | 2008 | 42 | 0.340 |
Why?
| | Transcription Factor RelA | 5 | 2009 | 82 | 0.320 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2008 | 341 | 0.290 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2008 | 420 | 0.280 |
Why?
| | Leukemia, Myeloid, Acute | 2 | 2022 | 532 | 0.270 |
Why?
| | Carrier Proteins | 1 | 2008 | 726 | 0.250 |
Why?
| | Endothelium, Vascular | 3 | 2006 | 907 | 0.250 |
Why?
| | Azacitidine | 2 | 2022 | 119 | 0.240 |
Why?
| | Protein Kinases | 1 | 2005 | 310 | 0.220 |
Why?
| | Gene Expression Regulation | 3 | 2008 | 2445 | 0.190 |
Why?
| | Protein Kinase Inhibitors | 2 | 2009 | 811 | 0.190 |
Why?
| | Graft vs Host Disease | 1 | 2022 | 216 | 0.180 |
Why?
| | Cell Nucleus | 3 | 2009 | 580 | 0.180 |
Why?
| | Phosphorylation | 5 | 2009 | 1633 | 0.150 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2022 | 540 | 0.150 |
Why?
| | TOR Serine-Threonine Kinases | 2 | 2008 | 369 | 0.120 |
Why?
| | Benzofurans | 1 | 2014 | 22 | 0.120 |
Why?
| | Triterpenes | 1 | 2014 | 17 | 0.120 |
Why?
| | Protein-Tyrosine Kinases | 2 | 2008 | 407 | 0.120 |
Why?
| | NF-KappaB Inhibitor alpha | 3 | 2009 | 52 | 0.110 |
Why?
| | I-kappa B Proteins | 3 | 2009 | 80 | 0.100 |
Why?
| | Leukemia | 1 | 2014 | 208 | 0.100 |
Why?
| | Phosphotyrosine | 2 | 2008 | 37 | 0.100 |
Why?
| | Cell Line | 2 | 2008 | 2707 | 0.100 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 2 | 2022 | 165 | 0.100 |
Why?
| | Hemostatics | 2 | 2008 | 50 | 0.100 |
Why?
| | Neoplastic Stem Cells | 1 | 2014 | 336 | 0.090 |
Why?
| | Cofilin 1 | 1 | 2009 | 5 | 0.090 |
Why?
| | Sirolimus | 2 | 2014 | 195 | 0.090 |
Why?
| | I-kappa B Kinase | 2 | 2008 | 50 | 0.080 |
Why?
| | Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2008 | 37 | 0.080 |
Why?
| | Sulfonamides | 2 | 2022 | 445 | 0.080 |
Why?
| | Embryo, Mammalian | 1 | 2008 | 220 | 0.080 |
Why?
| | Enzyme Activation | 2 | 2008 | 828 | 0.070 |
Why?
| | Signal Transduction | 3 | 2008 | 4709 | 0.070 |
Why?
| | Cytoskeleton | 1 | 2006 | 181 | 0.070 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2008 | 404 | 0.070 |
Why?
| | Actins | 1 | 2006 | 404 | 0.060 |
Why?
| | Drug Synergism | 1 | 2005 | 339 | 0.060 |
Why?
| | Fibroblasts | 1 | 2008 | 842 | 0.060 |
Why?
| | Cyclic AMP | 1 | 2004 | 242 | 0.060 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2004 | 285 | 0.060 |
Why?
| | Proto-Oncogene Proteins | 1 | 2006 | 618 | 0.060 |
Why?
| | Antineoplastic Agents | 1 | 2014 | 1974 | 0.050 |
Why?
| | Down-Regulation | 1 | 2005 | 627 | 0.050 |
Why?
| | Mice, Knockout | 1 | 2008 | 2680 | 0.050 |
Why?
| | Neoplasm, Residual | 1 | 2022 | 103 | 0.050 |
Why?
| | Induction Chemotherapy | 1 | 2021 | 59 | 0.050 |
Why?
| | Disease-Free Survival | 1 | 2022 | 649 | 0.050 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 2 | 2021 | 1390 | 0.050 |
Why?
| | Recurrence | 1 | 2022 | 975 | 0.040 |
Why?
| | Humans | 10 | 2022 | 118974 | 0.040 |
Why?
| | DNA-Binding Proteins | 1 | 2005 | 1346 | 0.040 |
Why?
| | Active Transport, Cell Nucleus | 2 | 2008 | 113 | 0.040 |
Why?
| | Mice | 2 | 2014 | 15520 | 0.040 |
Why?
| | Protein Processing, Post-Translational | 2 | 2009 | 408 | 0.030 |
Why?
| | DNA | 3 | 2008 | 1388 | 0.030 |
Why?
| | Retrospective Studies | 2 | 2022 | 12978 | 0.030 |
Why?
| | Cells, Cultured | 3 | 2008 | 4077 | 0.030 |
Why?
| | RNA, Messenger | 3 | 2006 | 2657 | 0.030 |
Why?
| | Antigens, CD34 | 1 | 2014 | 98 | 0.030 |
Why?
| | Protein Binding | 2 | 2008 | 1975 | 0.030 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2014 | 740 | 0.020 |
Why?
| | Reactive Oxygen Species | 1 | 2014 | 576 | 0.020 |
Why?
| | Animals | 2 | 2014 | 33381 | 0.020 |
Why?
| | Leukocytes, Mononuclear | 1 | 2014 | 509 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2021 | 6561 | 0.020 |
Why?
| | Adult | 2 | 2022 | 31512 | 0.020 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2014 | 455 | 0.020 |
Why?
| | Stress Fibers | 1 | 2009 | 18 | 0.020 |
Why?
| | Stem Cells | 1 | 2014 | 559 | 0.020 |
Why?
| | rhoA GTP-Binding Protein | 1 | 2009 | 80 | 0.020 |
Why?
| | rho-Associated Kinases | 1 | 2009 | 84 | 0.020 |
Why?
| | Syk Kinase | 1 | 2008 | 16 | 0.020 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2014 | 1167 | 0.020 |
Why?
| | Gene Knockdown Techniques | 1 | 2009 | 311 | 0.020 |
Why?
| | Mitochondria | 1 | 2014 | 786 | 0.020 |
Why?
| | Protein Transport | 1 | 2009 | 412 | 0.020 |
Why?
| | RNA Interference | 1 | 2009 | 460 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2014 | 1597 | 0.020 |
Why?
| | Phosphoserine | 1 | 2006 | 34 | 0.020 |
Why?
| | Dimerization | 1 | 2006 | 183 | 0.020 |
Why?
| | Young Adult | 1 | 2021 | 10793 | 0.020 |
Why?
| | Transcriptional Activation | 1 | 2008 | 348 | 0.020 |
Why?
| | src-Family Kinases | 1 | 2006 | 90 | 0.020 |
Why?
| | RNA Stability | 1 | 2006 | 97 | 0.020 |
Why?
| | Phenotype | 1 | 2014 | 3003 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2009 | 1158 | 0.020 |
Why?
| | Umbilical Veins | 1 | 2004 | 59 | 0.020 |
Why?
| | Apoptosis | 1 | 2014 | 2484 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2006 | 502 | 0.010 |
Why?
| | Aged | 1 | 2021 | 19657 | 0.010 |
Why?
| | Cell Adhesion | 1 | 2004 | 443 | 0.010 |
Why?
| | Models, Biological | 1 | 2009 | 1715 | 0.010 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2006 | 1171 | 0.010 |
Why?
| | Middle Aged | 1 | 2021 | 27617 | 0.010 |
Why?
| | Neutrophils | 1 | 2004 | 1233 | 0.010 |
Why?
| | Male | 1 | 2021 | 57801 | 0.010 |
Why?
| | Female | 1 | 2021 | 61565 | 0.010 |
Why?
|
|
Minhajuddin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|